Rapport Therapeutics (RAPP)
Nasdaq • RAPP • US75383L1026
ORTEX Data Highlights
ORTEX Data Highlights
As of Nov 3, 2026, ORTEX estimates 6.8% of free float is sold short, 2.1 days to cover, cost to borrow 0.82%.
Market Cap
1.53b USD | # 4362 in US
Volume
722.96k shares | 27.57m USD
Shares Outstanding
59.17m
Free Float Shares
78.05% | 46.18m
